3-47001748-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP6_Very_StrongBP7BA1

The NM_015175.3(NBEAL2):​c.4704C>T​(p.Asn1568Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0285 in 1,613,894 control chromosomes in the GnomAD database, including 2,181 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 226 hom., cov: 33)
Exomes 𝑓: 0.028 ( 1955 hom. )

Consequence

NBEAL2
NM_015175.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -4.83

Publications

7 publications found
Variant links:
Genes affected
NBEAL2 (HGNC:31928): (neurobeachin like 2) The protein encoded by this gene contains a beige and Chediak-Higashi (BEACH) domain and multiple WD40 domains, and may play a role in megakaryocyte alpha-granule biogenesis. Mutations in this gene are a cause of gray platelet syndrome. [provided by RefSeq, Dec 2011]
NBEAL2 Gene-Disease associations (from GenCC):
  • gray platelet syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP6
Variant 3-47001748-C-T is Benign according to our data. Variant chr3-47001748-C-T is described in ClinVar as Benign. ClinVar VariationId is 260580.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.83 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015175.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBEAL2
NM_015175.3
MANE Select
c.4704C>Tp.Asn1568Asn
synonymous
Exon 30 of 54NP_055990.1
NBEAL2
NM_001365116.2
c.4602C>Tp.Asn1534Asn
synonymous
Exon 29 of 53NP_001352045.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBEAL2
ENST00000450053.8
TSL:2 MANE Select
c.4704C>Tp.Asn1568Asn
synonymous
Exon 30 of 54ENSP00000415034.2
NBEAL2
ENST00000416683.5
TSL:1
c.2565C>Tp.Asn855Asn
synonymous
Exon 16 of 40ENSP00000410405.1
NBEAL2
ENST00000651747.1
c.4602C>Tp.Asn1534Asn
synonymous
Exon 29 of 53ENSP00000499216.1

Frequencies

GnomAD3 genomes
AF:
0.0304
AC:
4621
AN:
152188
Hom.:
226
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00765
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.117
Gnomad ASJ
AF:
0.0617
Gnomad EAS
AF:
0.131
Gnomad SAS
AF:
0.0494
Gnomad FIN
AF:
0.0145
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0171
Gnomad OTH
AF:
0.0277
GnomAD2 exomes
AF:
0.0612
AC:
15251
AN:
249078
AF XY:
0.0538
show subpopulations
Gnomad AFR exome
AF:
0.00808
Gnomad AMR exome
AF:
0.229
Gnomad ASJ exome
AF:
0.0616
Gnomad EAS exome
AF:
0.137
Gnomad FIN exome
AF:
0.0172
Gnomad NFE exome
AF:
0.0191
Gnomad OTH exome
AF:
0.0459
GnomAD4 exome
AF:
0.0283
AC:
41363
AN:
1461588
Hom.:
1955
Cov.:
31
AF XY:
0.0280
AC XY:
20342
AN XY:
727064
show subpopulations
African (AFR)
AF:
0.00621
AC:
208
AN:
33480
American (AMR)
AF:
0.214
AC:
9564
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0618
AC:
1615
AN:
26136
East Asian (EAS)
AF:
0.143
AC:
5685
AN:
39700
South Asian (SAS)
AF:
0.0421
AC:
3633
AN:
86258
European-Finnish (FIN)
AF:
0.0183
AC:
974
AN:
53298
Middle Eastern (MID)
AF:
0.0416
AC:
240
AN:
5768
European-Non Finnish (NFE)
AF:
0.0159
AC:
17656
AN:
1111862
Other (OTH)
AF:
0.0296
AC:
1788
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2569
5137
7706
10274
12843
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
878
1756
2634
3512
4390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0304
AC:
4629
AN:
152306
Hom.:
226
Cov.:
33
AF XY:
0.0331
AC XY:
2465
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00768
AC:
319
AN:
41556
American (AMR)
AF:
0.117
AC:
1783
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0617
AC:
214
AN:
3470
East Asian (EAS)
AF:
0.131
AC:
680
AN:
5178
South Asian (SAS)
AF:
0.0495
AC:
239
AN:
4832
European-Finnish (FIN)
AF:
0.0145
AC:
154
AN:
10614
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0171
AC:
1163
AN:
68038
Other (OTH)
AF:
0.0279
AC:
59
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
221
442
664
885
1106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0287
Hom.:
151
Bravo
AF:
0.0397
Asia WGS
AF:
0.0580
AC:
201
AN:
3478
EpiCase
AF:
0.0207
EpiControl
AF:
0.0190

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gray platelet syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
1.0
DANN
Benign
0.72
PhyloP100
-4.8
PromoterAI
0.029
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12489851; hg19: chr3-47043238; COSMIC: COSV52755552; COSMIC: COSV52755552; API